GLP-1R/Y2R agonist (Jiangsu Normal University)

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameGLP-1R/Y2R agonist (Jiangsu Normal University)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsNeuropeptide Y receptor type 2 agonists
TargetsGlucagon-like peptide 1 receptorNeuropeptide Y receptor type 2
Therapy Area/IndicationsObesityDiabetes MellitusFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Normal UniversityGuangxi Medical University Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Normal UniversityGuangxi Medical University Cancer Center
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A